All stock lists
Unlock the score
Ensysce Biosciences, Inc. (NASDAQ:ENSC)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.45-0.02 (-4.36%)
Insider Score
/ 100
ENSC Insider Score
Ensysce Biosciences, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
ENSC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.16 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.16 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 1.27 M | 1.18 M | 1.05 M | 1.28 M | 1.20 M | 1.40 M |
| R&D Expense | 2.47 M | 3.35 M | 3.61 M | 2.95 M | 1.92 M | 1.89 M |
| Operating Expenses | 3.74 M | 3.56 M | 2.78 M | 3.74 M | 1.75 M | 1.97 M |
| Operating Income | -2.58 M | -3.56 M | -2.78 M | -3.74 M | -1.75 M | -1.97 M |
| Pretax Income | -2.57 M | -3.56 M | -2.77 M | -3.73 M | -1.73 M | -1.95 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.57 M | -3.56 M | -2.77 M | -3.73 M | -1.73 M | -1.95 M |
| EPS (Basic) | -0.20 | -0.52 | -0.75 | -1.29 | -0.79 | -1.39 |
| EPS (Diluted) | -0.20 | -0.52 | -0.51 | -1.29 | -0.79 | -1.39 |
| Shares Outstanding | 13.04 M | 6.84 M | 2.56 M | 2.89 M | 2.20 M | 1.40 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.